TPD & Induced Proximity Summit Leaderboard
  • Saturday, July 11, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 460

Author

Pharma Journalist 8932 posts 0 comments

Humanized Chicken Antibody Technology to Drive Next Generation of Integral Molecular’s MPS…

Sep 11, 2020
Integral Molecular announces the development of Humanized Chicken Antibody Technology (hCAT) and the incorporation of hCAT into the company's industry-leading MPS antibody discovery…
Read More...

Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for…

Sep 11, 2020
Bayer and US-based Recursion Pharmaceuticals, Inc., a digital biology company industrializing drug discovery, have entered into a strategic collaboration agreement. The partnership will…
Read More...

Casma Therapeutics Announces $50 Million Series B Financing

Sep 10, 2020
Casma Therapeutics, Inc., a biotechnology company harnessing autophagy and the lysosome to design powerful new medicines, announced the completion of a $50 million Series B financing.…
Read More...

Ligand Expands OmniAb Antibody Discovery Platform Through the Acquisitions of xCella Biosciences and…

Sep 10, 2020
Ligand Pharmaceuticals Incorporated announces the acquisition of two privately held companies that strengthen and complement its OmniAb technology platform. Ligand acquired xCella…
Read More...

Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against…

Sep 10, 2020
Pfizer Inc. and BioNTech SE announced preliminary preclinical data in mouse and non-human primate models from their BNT162b2 mRNA-based vaccine program against SARS-CoV-2, the virus…
Read More...

Jazz Pharmaceuticals Announces New Research Collaboration with Redx Pharma to Discover and Develop…

Sep 10, 2020
Jazz Pharmaceuticals plc announced that the company has signed a new research collaboration agreement with Redx Pharma plc to discover and develop drug candidates for two cancer targets…
Read More...

Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO (ixazomib) in Newly…

Sep 10, 2020
Takeda Pharmaceutical Company Limited announced results from the Phase 3 TOURMALINE-MM2 trial evaluating the addition of NINLARO (ixazomib) to lenalidomide and dexamethasone versus…
Read More...

FDA approves Trelegy Ellipta as the first once-daily single inhaler triple therapy for the treatment…

Sep 10, 2020
GlaxoSmithKline plc and Innoviva, Inc. announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium /…
Read More...

AgeX Therapeutics and Lineage Cell Therapeutics Announce Expansion of Agreement Related to ESI…

Sep 9, 2020
AgeX Therapeutics, Inc. a company focused on developing and commercializing innovative therapeutics for human aging, and Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology…
Read More...

Huadong Medicine and Exscientia enter co-development partnership to accelerate oncology drug…

Sep 9, 2020
Exscientia and Huadong Medicine announced that the companies have entered into a co-development partnership to accelerate the discovery of breakthrough small-molecule therapeutics…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Roche Receives CE Mark for Elecsys Latent TB Test
  • Teva Secures Global Rights to Polpharma’s Ocrevus Biosimilar
  • Samsung Bioepis Partners With Proteina on AI Antibody Drug Discovery
  • Evogene, Tel Aviv University Launch AI Drug Discovery Initiative
  • Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.